Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Merrimack Pharmaceuticals
- Target Recruit Count
- 44
- Registration Number
- NCT00734305
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
๐บ๐ธThe Vanderbilt-Ingram Cancer Center, Nashville,, Tennessee, United States
๐บ๐ธFox Chase Cancer Center, Philadelphia, Pennsylvania, United States
A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
- First Posted Date
- 2007-04-09
- Last Posted Date
- 2008-03-27
- Lead Sponsor
- Merrimack Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00458146
- Locations
- ๐บ๐ธ
East Valley Rheumatology & Osteoporosis, Gilbert, Arizona, United States
๐บ๐ธArthritis and Rheumatic Disease Specialties, Aventura, Florida, United States
๐บ๐ธMontgomery Rheumatology Associates, Montgomery, Alabama, United States
Phase 2 Study of MM-093 to Treat Patients With Uveitis
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2008-12-18
- Lead Sponsor
- Merrimack Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT00444743
- Locations
- ๐บ๐ธ
MERSI, Cambridge, Massachusetts, United States
Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis
- Conditions
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2007-02-23
- Lead Sponsor
- Merrimack Pharmaceuticals
- Target Recruit Count
- 30
- Registration Number
- NCT00147329
- Locations
- ๐บ๐ธ
U. of Utah School of Medicine- Department of Dermatology, Salt Lake City, Utah, United States
๐บ๐ธTexas Dermatology Research Institute, Dallas, Texas, United States
Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)
- Conditions
- First Posted Date
- 2005-03-21
- Last Posted Date
- 2008-07-11
- Lead Sponsor
- Merrimack Pharmaceuticals
- Target Recruit Count
- 260
- Registration Number
- NCT00105976
- Locations
- ๐บ๐ธ
New England Research Associates, Bridgeport, Connecticut, United States
๐บ๐ธRheumatology Associates, PC, Indianapolis, Indiana, United States
๐บ๐ธHouston Institute for Clinical Research, Houston, Texas, United States